Editorial: More and more beta-blockers.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans
D000319:Adrenergic beta-Antagonists